NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC

Clinical trial NCT06966583 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06966583
Sponsor: Sichuan University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non Small Cell Lung Cancer

Start date: 2025-05-01
Primary completion: 2027-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.